Provided by Tiger Trade Technology Pte. Ltd.

OnKure Therapeutics, Inc.

2.60
-0.0400-1.52%
Volume:69.36K
Turnover:180.62K
Market Cap:35.23M
PE:-0.55
High:2.74
Open:2.64
Low:2.50
Close:2.64
52wk High:5.60
52wk Low:1.70
Shares:13.55M
Float Shares:5.81M
Volume Ratio:0.64
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7614
EPS(LYR):-15.2805
ROE:-207.36%
ROA:-96.53%
PB:0.53
PE(LYR):-0.17

Loading ...

Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
May 28, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 10, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2024

Correspondence

Form CORRESP - Correspondence
Oct 28, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]